Back
Sage Therapeutics Quote, Financials, Valuation and Earnings
Sponsored
SAGE
Sponsored
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
23
SAGE
Sage Therapeutics
Last Price:
5.82
Seasonality Move:
19.95%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret LoopholeSage Therapeutics Price Quote
$5.82
-0.23 (-3.8%)
(Updated: November 4, 2024 at 5:55 PM ET)
Sage Therapeutics Key Stats
Sell
23
Sage Therapeutics (SAGE)
is a Sell
Day range:
$5.84 - $6.16
52-week range:
$5.84 - $28.26
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.44
P/B ratio:
0.67%
Volume:
1.1M
Avg. volume:
724.6K
1-year change:
-69.29%
Market cap:
$370.1M
Revenue:
$86.5M
EPS:
$-5.57
How Much Does Sage Therapeutics Make?
-
How Much Are Sage Therapeutics's Sales Annually?
SAGE Revenues are $86.5M -
How Much Profit Does Sage Therapeutics's Make A Year?
SAGE net income is -$541.5M
Is Sage Therapeutics Growing As A Company?
-
What Is Sage Therapeutics's Growth Rate Quarterly?
Quarterly YoY revenue growth is 3.37% -
What Is Sage Therapeutics's EPS Quarterly YoY Growth Rate?
Quarterly, year-over-year diluted EPS growth rate is 0%
Sage Therapeutics Stock Price Performance
-
Did Sage Therapeutics Stock Go Up Last Month?
Sage Therapeutics share price went down by -13.07% last month -
Did SAGE's Share Price Rise Over The Last Year?
SAGE share price fell by -69.29% over the past 1 year
What Is Sage Therapeutics 52-Week High & Low?
-
What Is Sage Therapeutics’s 52-Week High Share Price?
Sage Therapeutics has traded as high as $28.26 over the past 52 weeks -
What Is Sage Therapeutics’s 52-Week Low Share Price?
Sage Therapeutics has traded as low as $5.84 over the past 52 weeks
Sage Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Sage Therapeutics?
-
How Much Debt Does Sage Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Sage Therapeutics Have?
Cash and short term investments quarterly total is $569.2M -
What Is Sage Therapeutics’s Book Value Per Share?
Book value per share is 9.02
Is Sage Therapeutics Cash Flow Positive?
-
What Is SAGE Cash Flow From Operations?
Cash flow from operations (TTM) is -$320.2M -
What Is Sage Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $10.4M -
What Is Sage Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is $262.2M
Sage Therapeutics Return On Invested Capital
-
Is Management Doing A Good Job?
SAGE return on invested capital is -48.2% -
What Is Sage Therapeutics Return On Assets?
ROA measures how assets are converting to revenues and is -43.07% -
What Is SAGE Return On Equity?
ROE is a measure of profitability and is -48.2%
Sage Therapeutics Earnings Date & Stock Price
-
What Is Sage Therapeutics's Stock Price Today?
A single share of SAGE can be purchased today for 6.05 -
What Is Sage Therapeutics’s Stock Symbol?
Sage Therapeutics trades on the nasdaq under the ticker symbol: SAGE -
When Is Sage Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Sage Therapeutics is scheduled on February 14, 2025 -
When Is SAGE's next ex-dividend date?
Sage Therapeutics's next ex-dividend date is November 5, 2024 -
How To Buy Sage Therapeutics Stock?
You can buy Sage Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Sage Therapeutics Competitors
-
Who Are Sage Therapeutics's Competitors?
Below is a list of companies who compete with Sage Therapeutics or are related in some way:
Sage Therapeutics Dividend Yield
-
What Is SAGE Dividend Yield?
Sage Therapeutics’s dividend yield currently is 0% -
What Is Sage Therapeutics’s Payout Ratio?
Sage Therapeutics’s payout ratio is 0% -
When Did Sage Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 5, 2024 -
What Is Sage Therapeutics’s Dividend Per Share?
Sage Therapeutics pays a dividend of $0.00 per share
Sage Therapeutics Analyst Estimates
YoY Growth | Past Surprise | |
---|---|---|
EPS: | 0% | 1.32% |
Revenue: | 337.08% | 6.76% |
Analyst Recommendations
Buy Recommendations: | 0 |
---|---|
Hold Recommendations: | 17 |
Sell Recommendations: | 0 |
Price Target: | 10.17 |
Upside from Last Price: | 68.04% |